Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
NISSAN TOKYO SALES, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 9%
8291 NISSAN TOKYO SALES HOLDINGS CO., LTD. 【J-GAAP】
Earnings ReportNISSAN TOKYO SALES HOLDINGS CO., LTD. <8291> [TSE Std] announced its financial results after the market closed on February 10th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) decreased 8.7% from the same period last year to 5.94 billion yen. However, the progress rate toward the full-year plan of 7 billion yen was 84.9%, also surpassing the five-year average of 57.8%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to drop 43.1% from the same period last year to 1.05 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit decreased to 2.17 billion yen, a 7.0% decrease compared to the same period last year. The operating profit margin worsened from 6.3% in the same period last year to 5.9%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 101,794 | 4,689 | 4,558 | 2,752 | 41.5 | 74.8 | Feb 6, 2023 | J-GAAP |
Apr - Dec, 2023 | 111,255 | 6,704 | 6,513 | 6,469 | 97.4 | 77.9 | Feb 9, 2024 | J-GAAP |
Apr - Dec, 2024 | 106,468 | 5,954 | 5,946 | 3,874 | 58.8 | 84.9 | Feb 10, 2025 | J-GAAP |
YoY | -4.3% | -11.2% | -8.7% | -40.1% | -39.6% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 74,614 | 4,316 | 4,194 | 4,894 | 73.7 | 15 | May 15, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 79,957 | 3,704 | 3,232 | 2,015 | 33.9 | 12 | Nov 13, 2024 | J-GAAP |
YoY | +7.2% | -14.2% | -22.9% | -58.8% | -54.0% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 137,659 | 6,399 | 6,090 | 3,261 | 49.2 | 15 | May 12, 2023 | J-GAAP |
Mar, 2024 | 148,972 | 8,709 | 8,364 | 7,337 | 110.5 | 24 | May 15, 2024 | J-GAAP |
Mar, 2025 Guidance | 150,000 | 7,500 | 7,000 | 4,500 | 75.7 | 24 | May 15, 2024 | J-GAAP |
YoY | +0.7% | -13.9% | -16.3% | -38.7% | -31.5% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 36,897 | 2,311 | 2,343 | 4,026 | 60.6 | 6.3 | Feb 9, 2024 | J-GAAP |
Jan - Mar, 2024 | 37,717 | 2,005 | 1,851 | 868 | 13.1 | 5.3 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 34,355 | 1,725 | 1,820 | 1,180 | 17.8 | 5.0 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 35,688 | 2,071 | 1,948 | 1,305 | 19.7 | 5.8 | Nov 13, 2024 | J-GAAP |
Oct - Dec, 2024 | 36,425 | 2,158 | 2,178 | 1,389 | 21.1 | 5.9 | Feb 10, 2025 | J-GAAP |
YoY | -1.3% | -6.6% | -7.0% | -65.5% | -65.2% |
Related Articles
CELM Inc, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 7%, Oct-Dec Ordinary Profit Decreases by 10%
TAZMO, Last Fiscal Year Ordinary Profit Revised Upward by 33%, Raises Record High Profit Forecast
KOBAYASHI PHARMA, 43% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
Immuno-Biological Lab, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5.2 times, Exceeds Full-Year Plan
Nippon Carbon, 2% Increase in Ordinary Profit for The Current Fiscal Year
Human Creation, Oct-Dec (1Q) Ordinary Profit Increases by 53%
MINATO HOLDINGS , Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 49%
Maruichi Steel Tube, The Current Fiscal Year Net Income Revised Upward to an Unexpected 2% Increase
SAYLOR ADVERTISING, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Widens, Oct-Dec Ordinary Profit Decreases by 90%
SOLXYZ, 25% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 1 yen